Health Canada has granted approval for Biogen’s Skyclarys (omaveloxolone) to treat Friedreich’s ataxia (FA), a rare, ...

Bill Nye critiqued HHS chief Robert F. Kennedy Jr. and his views on science and vaccines at a STAT event in New York.

In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...

Mirian Andino, 11, of Barnegat uses a motorized wheelchair to get around. Her parents need to raise $15,000 for a ...

At this point, there are several therapies which are coming along, a large trial called the ExRx trial, which included the nutraceutical, nicotinamide riboside has finished. The data are not yet ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

As the only approved treatment to address disease progression, SKYCLARYS addresses a long-standing gap in the care of Canadians living with Friedreich's ataxia Friedreich's ...

Biogen Canada Inc. is pleased to announce that Health Canada has approved SKYCLARYS™ (omaveloxolone) for the treatment of Friedreich's ataxia (FA) in patients 16 years of age and older.2 This approval ...

Overall, serious neurological events were uncommon in children aged 0 to 5 years, but more likely in those less than 2 years of age.

A team of researchers from the Universitat Politècnica de València (UPV) and the French National Centre for Scientific ...

Zeke is proud to be a Trinity Titan. His dad said a photo of two friends helping Zeke to the football field for a group picture shows the impact Zeke has had on his school and his community.